A revolutionary new coronavirus drug might be ready this summer

$%name A revolutionary new coronavirus drug might be ready this summer by Authcom, Nova Scotia\s Internet and Computing Solutions Provider in Kentville, Annapolis Valley$

Researchers are developing antibody-based drugs that could cure COVID-19 patients.
One company now says that the first monoclonal antibody medicine could be ready as soon as late summer.
The therapy is based on the same principle as plasma transfusions from donors who have survived a novel coronavirus infection.
Visit BGR’s homepage for more stories.

The two things that make the novel coronavirus so dangerous are its incredible contagiousness and the lack of drugs to treat COVID-19. That’s why face masks and social distancing measures are so important, and will still be required after regions start opening their economies. The virus won’t just disappear once the peak has passed and the curve has been flattened. It will continue to linger and significant outbreaks will still be possible. We’re getting better at treating the virus than we were a few months ago though, and the more time passes the closer we’ll be to a vaccine.

Remdesivir will become standard therapy for COVID-19, a drug that has been found to reduce the recovery time in some patients. The medication won’t reduce mortality rates, however, and it can’t prevent the infection. That’s what a vaccine would be able to deliver, assuming at least one drug ends up working out of more than 115 candidates currently in development. But we still have a long wait before a vaccine becomes widely available, so it’s a good thing that the first drugs capable of treating COVID-19 could be here as soon as this summer.

Continue reading…

Today’s Top Deals

Trending Right Now:

A revolutionary new coronavirus drug might be ready this summer originally appeared on BGR.com on Thu, 7 May 2020 at 10:52:22 EDT. Please see our terms for use of feeds.